Femoral Head Necrosis
9
0
2
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
11.1%
1 terminated out of 9 trials
50.0%
-36.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
Avenir® Cemented Hip Stem - PMCF
Observational Study to Collect Safety Data and PROMs on Primary THA
The Effect of Oxytocin Nasal Spray on Preventing Postoperative Delirium in Elderly Patients Undergoing Orthopedic Surgery
AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study
Anxiety Before Non-cardiac Surgery in Adults
Mortality and Related Risk Factors After Hip Arthroplasty
Donepezil Attenuate Postoperative Cognitive Dysfunction
Non-Interventional, Multicenter Bicontact® E PMCF Study